Re-examining the exclusion criterion of early recurrent ischemic stroke in intravenous thrombolysis: A meta-analysis

Current guidelines preclude the administration of intravenous tissue plasminogen activator in patients with early recurrent stroke (prior ischemic stroke within three months).

Source link

Related posts

A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management


Scientists use patient-derived neurons to develop new treatment strategy for Parkinson's disease


Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and ╬▒II-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World